Myriad Genetics | MYGN - Ebit

Stock Price
4.78
Daily Change
-0.01 -0.21%
Monthly
2.14%
Yearly
-35.58%
Q2 Forecast
4.68

Myriad Genetics reported $-3M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio-Rad Laboratories USD -418.8M 845.4M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Danaher USD 1.34B 158M Mar/2026
Illumina USD 256M 6M Dec/2025
J&J USD 6.62B 1.51B Mar/2026
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Quidel USD -37.3M 82.5M Dec/2025
Repligen USD 19.97M 3.16M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Standard Biotools USD -21.92M 10.97M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Veracyte USD 24.63M 1.52M Dec/2025
Waters USD 270.52M 78.4M Dec/2025